Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526212 · ClinicalTrials.gov registry record · Phase 3
Buprenorphine Group Medical Visits in Primary Care
A Phase 3 study of Opioid-Related Disorders, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02526212 is a Phase 3 study of Opioid-Related Disorders that has completed, run by Montefiore Medical Center. The registered enrollment target is 18 participants, below the 347-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02526212, a Phase 3 study of Opioid-Related Disorders, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this research is to improve the effectiveness of buprenorphine maintenance treatment (BMT) within primary care. Investigators propose that providing BMT as part of a group medical visit (instead of an individual visit) will improve treatment outcomes for patients with persistent opioid abuse, because members become accountable to the group, are exposed to beneficial habits of others (i.e. positive deviance), and can receive efficacious behavioral interventions concomitantly with medical management
Conditions Studied
Interventions
- BEHAVIORAL Treatment as usual
- DRUG Buprenorphine
- BEHAVIORAL G-BMT
Study Locations (1)
New York
- Comprehensive Health Care Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2019-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02526212
The ClinicalTrials.gov registry entry for NCT02526212 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 347-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (95% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid-Related Disorders appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual is the first listed.
NCT02526212 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02526212 about?
NCT02526212 is a clinical study titled "Buprenorphine Group Medical Visits in Primary Care". The primary goal of this research is to improve the effectiveness of buprenorphine maintenance treatment (BMT) within primary care. Investigators propose that providing BMT as part of a group medical visit (instead of an individual visit) will improve treatment outcomes for patients with persistent...
What is the current status of trial NCT02526212?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 18 participants. The study started on 2017-01-01. Estimated completion is 2019-05.
What conditions does trial NCT02526212 study?
This clinical trial studies the following conditions: Opioid-Related Disorders.
What interventions are being tested in trial NCT02526212?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), Buprenorphine (DRUG), G-BMT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02526212?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02526212 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
ACTIVE NOT RECRUITING · Phase 3
-
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
COMPLETED · Phase 3
-
Medication Treatment for Opioid Use Disorder in Expectant Mothers
COMPLETED · Phase 3
-
Open-Label Treatment Extension Study
COMPLETED · Phase 3
-
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.